Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities

Abstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many different modalities are used for its management, such a...

Full description

Bibliographic Details
Main Authors: Ahmed Khater, Mohammad Waheed El-Anwar, Ahmad Abdel-Fattah Nofal, Atef Taha Elbahrawy
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2018-07-01
Series:International Archives of Otorhinolaryngology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1605376
id doaj-c0d2bf0ac93a4fd390da6a0dc1663ef0
record_format Article
spelling doaj-c0d2bf0ac93a4fd390da6a0dc1663ef02020-11-25T02:32:40ZengThieme Revinter Publicações Ltda.International Archives of Otorhinolaryngology1809-97771809-48642018-07-01220324524910.1055/s-0037-1605376Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment ModalitiesAhmed Khater0Mohammad Waheed El-Anwar1Ahmad Abdel-Fattah Nofal2Atef Taha Elbahrawy3Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptAbstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many different modalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances. Objectives This study aims to evaluate the efficacy of the combination of the most common treatment modalities of ISSNHL and to compare the results if HOT was not one of the treatment modalities administered. Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT. Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7. Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1605376hearing losshyperbaric oxygen therapysteroidsintratympanic injection
collection DOAJ
language English
format Article
sources DOAJ
author Ahmed Khater
Mohammad Waheed El-Anwar
Ahmad Abdel-Fattah Nofal
Atef Taha Elbahrawy
spellingShingle Ahmed Khater
Mohammad Waheed El-Anwar
Ahmad Abdel-Fattah Nofal
Atef Taha Elbahrawy
Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
International Archives of Otorhinolaryngology
hearing loss
hyperbaric oxygen therapy
steroids
intratympanic injection
author_facet Ahmed Khater
Mohammad Waheed El-Anwar
Ahmad Abdel-Fattah Nofal
Atef Taha Elbahrawy
author_sort Ahmed Khater
title Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
title_short Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
title_full Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
title_fullStr Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
title_full_unstemmed Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities
title_sort sudden sensorineural hearing loss: comparative study of different treatment modalities
publisher Thieme Revinter Publicações Ltda.
series International Archives of Otorhinolaryngology
issn 1809-9777
1809-4864
publishDate 2018-07-01
description Abstract Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many different modalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances. Objectives This study aims to evaluate the efficacy of the combination of the most common treatment modalities of ISSNHL and to compare the results if HOT was not one of the treatment modalities administered. Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT. Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7. Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL.
topic hearing loss
hyperbaric oxygen therapy
steroids
intratympanic injection
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1605376
work_keys_str_mv AT ahmedkhater suddensensorineuralhearinglosscomparativestudyofdifferenttreatmentmodalities
AT mohammadwaheedelanwar suddensensorineuralhearinglosscomparativestudyofdifferenttreatmentmodalities
AT ahmadabdelfattahnofal suddensensorineuralhearinglosscomparativestudyofdifferenttreatmentmodalities
AT ateftahaelbahrawy suddensensorineuralhearinglosscomparativestudyofdifferenttreatmentmodalities
_version_ 1724818612878835712